Literature DB >> 15629010

Amorphous pharmaceutical solids.

Edina Vranić1.   

Abstract

Amorphous forms are, by definition, non-crystalline materials which possess no long-range order. Their structure can be thought of as being similar to that of a frozen liquid with the thermal fluctuations present in a liquid frozen out, leaving only "static" structural disorder. The amorphous solids have always been an essential part of pharmaceutical research, but the current interest has been raised by two developments: a growing attention to pharmaceutical solids in general, especially polymorphs and solvates and a revived interest in the science of glasses and the glass transition. Amorphous substances may be formed both intentionally and unintentionally during normal pharmaceutical manufacturing operations. The properties of amorphous materials can be exploited to improve the performance of pharmaceutical dosage forms, but these properties can also give rise to unwanted effects that need to be understood and managed in order for the systems to perform as required.

Entities:  

Mesh:

Year:  2004        PMID: 15629010      PMCID: PMC7245478          DOI: 10.17305/bjbms.2004.3383

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  15 in total

1.  Interpretation of relaxation time constants for amorphous pharmaceutical systems.

Authors:  S L Shamblin; B C Hancock; Y Dupuis; M J Pikal
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

2.  Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance.

Authors:  Bruno C Hancock; Glenn T Carlson; Dauda D Ladipo; Beth A Langdon; Matthew P Mullarney
Journal:  Int J Pharm       Date:  2002-07-08       Impact factor: 5.875

Review 3.  The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems.

Authors:  D Q Craig; P G Royall; V L Kett; M L Hopton
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

Review 4.  Assessment of disorder in crystalline powders--a review of analytical techniques and their application.

Authors:  G Buckton; P Darcy
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

5.  Formation of glasses from liquids and biopolymers.

Authors:  C A Angell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

6.  Packing structures and transitions in liquids and solids.

Authors:  F H Stillinger; T A Weber
Journal:  Science       Date:  1984-09-07       Impact factor: 47.728

Review 7.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

8.  Effects of sorbed water on the crystallization of indomethacin from the amorphous state.

Authors:  V Andronis; M Yoshioka; G Zografi
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

9.  Determination of the glass properties of D-mannitol using sorbitol as an impurity.

Authors:  L Yu; D S Mishra; D R Rigsbee
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

10.  The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids.

Authors:  B C Hancock; G Zografi
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.